4.6 Letter

Efficacy and safety of low-dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Dermatology

Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis

Francois Chasset et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Article Dermatology

Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience

Scott A. Kindle et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)

Letter Dermatology

Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients

Feriel Fennira et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Letter Dermatology

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial

Lauren Okon et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)

Article Rheumatology

Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus

Josefina Cortes-Hernandez et al.

ARTHRITIS RESEARCH & THERAPY (2012)